PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.36−0.68 (-13.49%)
Close on Nov 13, 2026Market cap $301.97MP/E –Yield –
PepGen total assets
Total assets on the balance sheet at the end of each period.
PepGen's total assets was $127.78M at Sep 30, 2026. For fiscal 2025 it was $173.91M, up 15.3% from the year before. The highest annual figure on record is $217.44M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $173.91M | +15.3% |
| FY2024 | Dec 31, 2024 | $150.88M | +5.5% |
| FY2023 | Dec 31, 2023 | $143.05M | -34.2% |
| FY2022 | Dec 31, 2022 | $217.44M | +51.4% |
| FY2021 | Dec 31, 2021 | $143.64M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $127.78M | -32.8% |
| Q2 FY2026 | Jun 30, 2026 | $141.40M | +38.3% |
| Q1 FY2026 | Mar 31, 2026 | $156.30M | +22.7% |
| Q4 FY2025 | Dec 31, 2025 | $173.91M | +15.3% |
| Q3 FY2025 | Sep 30, 2025 | $190.06M | +11.6% |
| Q2 FY2025 | Jun 30, 2025 | $102.24M | -47.2% |
| Q1 FY2025 | Mar 31, 2025 | $127.39M | -38.5% |
| Q4 FY2024 | Dec 31, 2024 | $150.88M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $170.23M | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $193.51M | +6.3% |
| Q1 FY2024 | Mar 31, 2024 | $207.00M | +3.0% |
| Q4 FY2023 | Dec 31, 2023 | $143.05M | -34.2% |
| Q3 FY2023 | Sep 30, 2023 | $164.27M | -21.2% |
| Q2 FY2023 | Jun 30, 2023 | $182.09M | -21.1% |
| Q1 FY2023 | Mar 31, 2023 | $201.04M | +52.4% |
| Q4 FY2022 | Dec 31, 2022 | $217.44M | +51.4% |
| Q3 FY2022 | Sep 30, 2022 | $208.46M | – |
| Q2 FY2022 | Jun 30, 2022 | $230.80M | – |
| Q1 FY2022 | Mar 31, 2022 | $131.88M | – |
| Q4 FY2021 | Dec 31, 2021 | $143.64M | – |
See a number that looks wrong?